What changed in this filing

/stocks — the workspaceLOADING

Item 2. Management’s Discussion and Analysis

2023-11-28 compared with 2023-10-17 · 35 added, 34 removed, 153 unchanged (31% of the section changed)

78 unchanged sentences

Results of Operations for the three months

ended June 30, 2023 and 2022

Three months ended June 30,

ended September 30, 2023 and 2022

Three months ended September 30,

Operating expenses:

7 unchanged sentences

Operating expenses

three months ended June 30, 2023, our total operating expenses included general and administrative expenses of $67,620 as compared to

$31,211 during the three months ended June 30, 2022.

three months ended September 30, 2023, our total operating expenses included general and administrative expenses of $59,194 as compared

to $33,313 during the three months ended September 30, 2022.

T he $25,881 increase is primarily associated with increases in professional

1 unchanged sentence

Other income (expense)

three months ended June 30, 2023, total other income was $20,053 as compared to other expense

of $400,870 during the three months ended June 30, 2022.

The $420,923 increase was mainly related to the change in derivative liability.

Results of Operations for the six months

ended June 30, 2023 and 2022

Six months ended June 30,

the three months ended September 30, 2023, total other income was $122,052

as compared to other expense of $43,417 during the three months ended September 30, 2022.

$78,635 increase was mainly related to the change in derivative

Results of Operations for the nine months

ended September 30, 2023 and 2022

Nine months ended September 30,

Operating expenses:

7 unchanged sentences

Operating expenses

six months ended June 30, 2023, our total operating expenses included general and administrative expenses of $101,565 as compared to $99,808

during the six months ended June 30, 2022.

nine months ended September 30, 2023, our total operating expenses included general and administrative expenses of $160,759 as compared

to $133,121 during the nine months ended September 30, 2022.

T he $27,638 increase is primarily associated with increases in professional

and consulting fees.

Other income (expense)

six months ended June 30, 2023, total other income was $23,077 as compared to other expense

of $437,019 during the six months ended June 30, 2022.

The $460,096 increase was mainly related to the change in derivative liability.

the nine months ended September 30, 2023, total other income was $98,975 as

compared to other expense of $480,436 during the nine months ended September 30, 2022.

The $381,461 decrease was mainly

related to the change in derivative liability and decrease of the amortization of debt discount in 2023.

Liquidity and Capital Resources

5 unchanged sentences

unable to continue as a going concern.

At June 30, 2023, we had not yet generated sufficient revenues or achieved profitable operations

At September 30, 2023, we had not yet generated sufficient revenues or achieved profitable operations

and we have accumulated losses of $19,789,476.

9 unchanged sentences

operating, investing and financing activities is as follows:

Six months ended June 30,

Nine months ended September 30,

Net cash used in operating activities

4 unchanged sentences

Cash end of period

At June 30, 2023, we had $2,795 in cash and a

$1,617,550 working capital deficit.

At September 30, 2023, we had $12,885 in cash

and a $1,778,602 working capital deficit.

This compares to cash of $743 and a working capital deficit of $1,692,051 at December 31, 2022.

Net cash used in operating activities during the

six months ended June 30, 2023 was $54,247 and was mainly comprised of our $78,488 net loss during the period, adjusted by a non-cash

charges of $12,989 of stock compensation, accretion of discounts on notes payable of $8,019 and a gain on change in derivative liability

nine months ended September 30, 2023 was $56,757 and was mainly comprised of our $259,734 net loss during the period, adjusted by a non-cash

charges of $20,583 of stock compensation, accretion of discounts on notes payable of $10,000 and a loss on change in derivative liability

In addition, it reflects changes in operating assets and liabilities of $142,318.

Net cash used in operating activities during the

six months ended June 30, 2022 was $85,288 and was mainly comprised of our $536,827 net loss during the period, adjusted by

a non-cash charges of $18,608 of stock compensation, loss on change in derivative liability of $277,012 and accretion of discounts on

notes payable of $122,362.

used in operating activities during the nine months ended September 30, 2022 was $131,853 and was mainly comprised of our $613,557 net

loss during the period, adjusted by a non-cash charges of $29,408 of stock compensation, loss on change in derivative liability of $238,640

and accretion of discounts on notes payable of $183,147.

In addition, it reflects changes in operating assets and liabilities of $30,509.

Net cash used in investing activities during the

six months ended June 30, 2023 was $100,000 which was comprised of cash payment for acquisition of mineral properties.

nine months ended September 30, 2023 was $100,000 which was comprised of cash payment for acquisition of mineral properties.

Net cash used in investing activities during the

six months ended June 30, 2022 was $769 which was comprised of cash payments for development costs.

During the six months ended June 30, 2023, net

cash provided by financing activities was $156,299 which was comprised of $240,000 proceeds from sale of common stock, $21,000

proceeds from notes payable, third parties , which were offset with the repayment of convertible debt of $100,000 and repayment

of advances from third parties of $4,701.

During the six months ended June 30, 2022, net

cash provided by financing activities was $70,000 comprised of $40,000 proceeds from notes payable and $30,000 proceeds from notes payable

from related parties.

nine months ended September 30, 2022 was $769 which was comprised of cash payments for development costs.

During the nine months ended September 30, 2023,

net cash provided by financing activities was $168,899 which was comprised of $252,600 proceeds from sale of common stock, $21,000 proceeds

from notes payable, third parties, which were offset with the repayment of convertible debt of $100,000 and repayment of advances from

third parties of $4,701.

nine months ended September 30, 2022, net cash provided by financing activities was $116,000 comprised of $63,000 proceeds from notes

payable and $53,000 proceeds from notes payable from related parties.

Off Balance Sheet Arrangements

21 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 2. Management’s Discussion and Analysis